The Inflammatory CXC Chemokines, GROα, IP-10, and MIG, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression.

AIMS

To investigate the clinical significance of tumor tissue-infiltrating chemokines expression in non-small cell lung cancer (NSCLC) microenvironment.

MATERIALS AND METHODS

Fresh tissue samples were acquired from 50 patients with NSCLC after operation. Then, we quantified the total protein with the BCA Protein Assay Kit and tested 13 chemotactic factors in paired samples including tumor tissues, tumor adjacent tissues, and normal tissues with the CBA Kit.

RESULTS

We found that the chemokine CC subfamily of MCP-1, MIP-1α, MIP-1β, and MIP-3α and the chemokine CXC subfamily of IL-8, GROα, IP-10, and MIG expressions in tumor tissues were significantly higher than those in tumor-adjacent tissues and normal tissues. However, regulated upon activation normal T cell expressed and secreted (RANTES), human thymus activation regulated chemokine (TARC), chemokine (C-C motif) ligand 11 (CCL11), interferon-inducible T cell alpha chemoattractant (I-TAC), and ENA-78 expressions did not show significant difference. Analyzing the influence of chemokine expression level in tumor tissues on disease progression, we found the median progression-free survival (mPFS) of patients with GROα was significantly lower than those with GROα; mPFS of patients with IP-10 was significantly lower than those with IP-10; and mPFS of patients with MIG was significantly lower than those with MIG. However, MCP-1, MIP-1α, MIP-1β, MIP-3α, and IL-8 had no significant value to elevate the mPFS of patients with NSCLC.

CONCLUSION

In summary, tumor tissue-infiltrating CXC chemokines, GROα, IP-10, and MIG in the tumor microenvironment can be used as potential indicators for the progression of NSCLC.